HOME

akominmin様3点おまとめユリエニタニ INDIVI ICB

Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry

Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma | npj Precision Oncology

商品説明・詳細
送料・お届け

商品情報

Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry,Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry,Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry,Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma | npj Precision Oncology,Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry

残り 1 点 6020円

（1 ポイント還元！）

翌日お届け可（営業日のみ） ※一部地域を除く

お届け日: 05月07日〜指定可お届け日: (明日12:00のご注文まで)

ラッピング

対応決済方法

クレジットカード
コンビニ前払い決済
代金引換: 商品到着と引き換えにお支払いいただけます。 (送料を含む合計金額が￥299,000 まで対応可能)
ペイジー前払い決済(ATM/ネットバンキング): 以下の金融機関のATM/ネットバンクからお支払い頂けます
みずほ銀行、三菱ＵＦＪ銀行、三井住友銀行
りそな銀行、ゆうちょ銀行、各地方銀行
Amazon Pay(Amazonアカウントでお支払い)